Replies to post #175512 on Biotech Values

[acgood]

ICPT

It’s generally a bearish sign when a biotech company dismisses a kind of SAE because it wasn’t statsig more frequent on drug than on placebo.

As I tweeted, the patients affected could have been split 6 vs 1 (100 per arm) and the difference would be "not statistically significant"